Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 127717-18-4 | MDL No. : | MFCD12405113 |
Formula : | C10H10N2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | SRCMADUBXYBMGV-UHFFFAOYSA-N |
M.W : | 190.20 | Pubchem ID : | 14642208 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.2 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 51.44 |
TPSA : | 43.6 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.55 cm/s |
Log Po/w (iLOGP) : | 2.32 |
Log Po/w (XLOGP3) : | 1.28 |
Log Po/w (WLOGP) : | 1.43 |
Log Po/w (MLOGP) : | 1.61 |
Log Po/w (SILICOS-IT) : | 1.22 |
Consensus Log Po/w : | 1.57 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.17 |
Solubility : | 1.29 mg/ml ; 0.00677 mol/l |
Class : | Soluble |
Log S (Ali) : | -1.8 |
Solubility : | 3.05 mg/ml ; 0.016 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.55 |
Solubility : | 0.534 mg/ml ; 0.00281 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.66 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 936637-97-7 ]
Methyl 5-formylpyrazolo[1,5-a]pyridine-3-carboxylate
Similarity: 0.96
[ 99446-50-1 ]
Dimethyl pyrazolo[1,5-a]pyridine-3,5-dicarboxylate
Similarity: 0.95
[ 51135-70-7 ]
Ethyl 5-methylpyrazolo[1,5-a]pyridine-3-carboxylate
Similarity: 0.95
[ 127717-19-5 ]
Methyl 4-methylpyrazolo[1,5-a]pyridine-3-carboxylate
Similarity: 0.94
[ 1092351-82-0 ]
Methyl 1-methyl-1H-indazole-5-carboxylate
Similarity: 0.90
[ 936637-97-7 ]
Methyl 5-formylpyrazolo[1,5-a]pyridine-3-carboxylate
Similarity: 0.96
[ 99446-50-1 ]
Dimethyl pyrazolo[1,5-a]pyridine-3,5-dicarboxylate
Similarity: 0.95
[ 51135-70-7 ]
Ethyl 5-methylpyrazolo[1,5-a]pyridine-3-carboxylate
Similarity: 0.95
[ 127717-19-5 ]
Methyl 4-methylpyrazolo[1,5-a]pyridine-3-carboxylate
Similarity: 0.94
[ 16205-46-2 ]
Pyrazolo[1,5-a]pyridine-3-carboxylic acid
Similarity: 0.91